It was the objective of this study to compare the antithrombotic effects and bleeding profiles of the oral direct thrombin inhibitor ximelagatran, an anticoagulant, and the antiplatelet agent clopidogrel on top of steady-state acetylsalicylic acid (ASA) in a human arterial thrombosis model...
Keywords: clinical trials, oral anticoagulants, coagulation inhibitors,thrombin
03/2006 | Thrombosis and Haemostasis, Schattauer